Cubist Systematic Strategies’s Sanofi SNY Stock Holding History

Cubist Systematic Strategies’s Portfolio SNY Stock Details SNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-411	Closed	-$19.9K	–	4379
2022 Q4	$19.9K	Hold	411	–	–	﹤0.01%	3994
2022 Q3	$16K	Hold	411	–	–	﹤0.01%	4251
2022 Q2	$21K	Hold	411	–	–	﹤0.01%	4216
2022 Q1	$21K	Hold	411	–	–	﹤0.01%	3474
2021 Q4	$21K	Buy	+411	New	+$20.3K	﹤0.01%	3374

Other funds holding SNY

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

Cubist Systematic Strategies's SNY Position: Q1 2023 in Review

Cubist Systematic Strategies sold out of Sanofi (SNY) in Q1 2023, closing a stake of 411 shares — an estimated $19.9K sold.

Cubist Systematic Strategies first reported a position in SNY in Q4 2021 and held it in 5 quarters. The position peaked at $21K in Q2 2022. 678 funds tracked by Wall St. Rank hold SNY as of Q1 2023.

Cubist Systematic Strategies reported no remaining Sanofi position as of Q1 2023 after selling out during the quarter.
Cubist Systematic Strategies sold 411 Sanofi shares in Q1 2023, an estimated $19.9K.
Cubist Systematic Strategies first reported a position in Sanofi in Q4 2021 and held it in 5 quarters.
Cubist Systematic Strategies's Sanofi position peaked at $21K in Q2 2022.
678 funds tracked by Wall St. Rank held Sanofi as of Q1 2023.

Based on Cubist Systematic Strategies's 13F filing for Q1 2023, filed 15 May 2023.